Computational Models for Ocular Drug Repurposing of a Ribosomal S6 Kinase Inhibitor (RSKi) in Treatment of Retinal Degenerative Diseases

被引：0
|
作者：
Mikayelyan, Lilit [1 ]
Terneus, Marcus [2 ]
Bramhall, Jessica [2 ]
Bell, Sammy [2 ]
Gukasyan, Hovhannes J. [1 ]
机构：
[1] Univ Southern Calif, Mann Sch Pharm & Pharmaceut Sci, Los Angeles, CA USA
[2] Boehringer Ingelheim Pharmaceut Inc, External Alternat CMC Dev, Ridgefield, CT USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6128
引用
收藏
页数：2
相关论文
共 33 条
  • [31] DIACC3010, optimized inhibitor of S6 kinase, combined with endocrine therapy, has potent antitumor activity in treatment-resistant ER-positive HER2-negative metastatic breast cancer
    Navarro, Christel
    Tsimberidou, Apostolia Maria
    Bougeret, Cecile
    Borghi, Elsa
    Bridon, Dominique
    Sicard, Helene
    CANCER RESEARCH, 2023, 83 (07)
  • [32] The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1
    D Neise
    D Sohn
    A Stefanski
    H Goto
    M Inagaki
    S Wesselborg
    W Budach
    K Stühler
    R U Jänicke
    Cell Death & Disease, 2013, 4 : e859 - e859
  • [33] The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1
    Neise, D.
    Sohn, D.
    Stefanski, A.
    Goto, H.
    Inagaki, M.
    Wesselborg, S.
    Budach, W.
    Stuehler, K.
    Jaenicke, R. U.
    CELL DEATH & DISEASE, 2013, 4 : e859 - e859
1234